Seth Harmon - 10 Nov 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Senior Vice President of Finance
Signature
/s/ Seth Harmon
Issuer symbol
VRDN
Transactions as of
10 Nov 2023
Net transactions value
$0
Form type
4
Filing time
13 Nov 2023, 17:17:05 UTC
Previous filing
19 Sep 2023
Next filing
04 Mar 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +270,000 $0.000000 270,000 10 Nov 2023 Common Stock 270,000 $13.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Senior Vice President of Finance